Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract

• Published in: Urology (Ridgewood, N.J.) Vol. 68; no. 1; pp. 53 - 57
• Main Authors: Kwak, Cheol, Lee, Sang Eun, Jeong, In Gab, Ku, Ja Hyeon
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.07.2006; Elsevier Science
• Subjects: Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Carcinoma, Transitional Cell - drug therapy; Carcinoma, Transitional Cell - mortality; Carcinoma, Transitional Cell - secondary; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Kidney Neoplasms - drug therapy; Kidney Neoplasms - mortality; Kidney Neoplasms - pathology; Male; Medical sciences; Middle Aged; Neoplasm Recurrence, Local; Nephrology. Urinary tract diseases; Survival Rate; Ureteral Neoplasms - drug therapy; Ureteral Neoplasms - mortality; Ureteral Neoplasms - pathology; Human; Chemotherapy; Nephrology; Adjuvant treatment; Systemic; Malignant tumor; Transitional cell carcinoma; Disseminated; Infiltrating tumor; Urology

To evaluate the efficacy of adjuvant systemic chemotherapy in conjunction with surgery in patients with invasive transitional cell carcinoma of the upper urinary tract. From January 1991 to May 2001, 36 men and 7 women had invasive (Stage pT2 or worse), but not metastatic, disease and were the subje...